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Abstract
Background: Human bocavirus is a newly discovered parvovirus. Multiple studies have confirmed the presence of
human bocavirus1 (HBoV1) in respiratory tract samples of children. The viral load, presentation of single detection
and its role as a causative agent of severe respiratory tract infections have not been thoroughly elucidated.
Methods: We investigated the presence of HBoV1 by quantitative polymerase chain reaction (PCR) of
nasopharyngeal aspirate specimens from 1229 children hospitalized for respiratory tract infections. The samples
were analyzed for 15 respiratory viruses by PCR and 7 respiratory viruses by viral culture.
Results: At least one virus was detected in 652 (53.1%) of 1229 children, and two or more viruses were detected in
266 (21.6%) children. HBoV1 was detected in 127 children (10.3%), in which 66/127 (52%) of the cases were the only
HBoV1 virus detected. Seasonal variation was observed with a high HBoV1 infection rate in summer. A cutoff value
of 107 copies/mL was used to distinguish high and low HBoV1 viral loads in the nasopharyngeal aspirates. High
viral loads of HBoV1 were noted predominantly in the absence of other viral agents (28/39, 71.8%) whereas there
was primarily co-detection in cases of low HBoV1 viral loads (50/88, 56.8%). There were no differences in the clinical
symptoms and severity between HBoV1 single detection and co-detection. In cases of HBoV1 single detection,
the high viral load group was more prevalent among children with dyspnea and wheezing than was the low viral
load group (42.9% vs. 23.7%, P = 0.036; 60.7% vs. 31.6%, P = 0.018). In clinical severity, a significant difference was
recorded (25.0% vs. 5.3%, P = 0.003) between high viral load and low viral load groups. Of the HBoV1 positive
patients associated with severe respiratory tract infections, 10/18 (55.6%) patients belonged to the HBoV1 high
viral load group, and 7/10 (70%) patients had cases of HBoV1 single detection.
Conclusions: HBoV1 at a high viral load is not frequently found in co-detection with other respiratory viruses,
and a single detection with a high viral load could be an etiological agent of severe respiratory tract infections.
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Background
Human bocavirus (HBoV) was first described in 2005 in
nasopharyngeal aspirates (NPAs) of children with re-
spiratory tract infections (RTI). Although the prevalence
of HBoV in humans has been studied in some regions, it
has not been well addressed globally [1]. Nearly all
prevalence studies have been done on respiratory tract
secretions from patients (predominantly children) with
RTI, and prevalence rates of between 1.5% and 19% have
been observed [2].
Our current knowledge of HBoV1 infection suggests
that the virus is sometimes a passenger and sometimes a
pathogen in acute respiratory tract disease. Allander sug-
gested a model for HBoV infection in which high viral
loads are potentially associated with respiratory symp-
toms, and low viral loads indicate asymptomatic shed-
ding [3]. Jacques reported that HBoV at a high viral load
could be an etiological agent of respiratory tract disease
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[4]. The patients positive only for HBoV predominantly
constituted the high viral load group, whereas most of
the HBoV-positive patients with infection caused by
other respiratory viruses belonged to the low viral load
group [4-6]. Martin reported that HBoV positivity did
not consistently correspond with the onset of respiratory
illness, and its load did not correlate with the severity of
illness [7]. Recent results obtained by quantitative real-
time PCR suggest that high HBoV viral loads (defined as
> 106copies/mL) are frequently present as the sole viral
finding for children admitted for RTI [4,5,8]. However,
the role of HBoV as a causative agent in severe respira-
tory tract infections (SRTI) is unclear.
HBoV infection has recently attracted increasing at-
tention all over the world. The incidence and clinical
presentation of this infection varies widely, and often
involves co-infection with other potential pathogens [9].
Respiratory syncytial virus (RSV) was the most prevalent
pathogen associated with HBoV in all the studies [2,10-13].
Such characteristics have led to debate over the role of
HBoV as a true pathogen. Therefore, additional evidence
and studies are needed throughout the world to gain a bet-
ter understanding of this virus. We investigated whether
HBoV1 at a high viral load increases the severity of RTI
and whether co-detection with HBoV1 and another respira-
tory virus or viruses increases the severity of concurrent
viral detection. We study the prevalence of HBoV1 and the
genome of the HBoV1 load in respiratory tract specimens
from children hospitalized for RTI to investigate the
association between HBoV1 detection and SRTI. This
article might increase our understanding of the role of
HBoV1 in SRTI.
Methods
Study subjects and sample collection
Between December 2009 and August 2013, we recruited
1229 children with RTI (the clinical systems included
cough, expectoration, tachypnea, and wheezing) from the
Department of Respiratory Medicine at the Children’s
Hospital of Chongqing Medical University in China. NPAs
were collected when the patients were admitted to our de-
partment. The specimens were kept at 4°C for a maximum
of 4 h and stored at −80°C until further processing. This
study was authorized by the Ethics Committee of the
Children’s Hospital of Chongqing Medical University.
The guardians of the patients signed informed consent
forms for participation in this study and for the publica-
tion of individual clinical details.
Diagnosis of SRTI
SRTI was assessed according to respiratory failure con-
firmed by an abnormal blood gas analysis result (based on
the potential of hydrogen, partial pressure CO2, partial
pressure O2, an oxygen saturation level of approximately
90% or less and the need for oxygen therapy) or by being a
patient in intensive care unit (ICU) for mechanical ventila-
tion treatment [14].
Virus isolation
Viral culture was performed for 7 respiratory viruses for
all samples: adenovirus (ADV), influenza virus A and B
(IVA and IVB), parainfluenza virus types 1–3 (PIV1–3)
and RSV [15]. Human epidermoid carcinoma Hep-2
cells were maintained in Dulbecco Modified Eagle’s
Medium (DMEM) supplemented with 10% fetal bovine
serum (FBS), 50 U/mL penicillin and 50-g/mL strepto-
mycin (from Invitrogen, Carlsbad, CA). The cells were
seeded and cultured to 70 to 80% confluence, and the
clinical specimens were inoculated in the Hep-2 cells
and cultured for 2 h. Next, the inoculum was aspirated
and the Hep-2 cells were washed twice with phosphate
buffered saline (PBS) and re-fed with fresh DMEM sup-
plemented with 2% FBS. The cells were scraped when
the cytopathic effect (CPE) involved at least 75% of the
Hep-2 cell monolayer, after which the virus-cell suspen-
sions were collected, aliquoted and stored at −80°C. If
the cells showed no CPE after being cultured for 7 days,
they were scraped, and the cell suspension was collected
for a second inoculation. For CPE positive samples, virus
nucleic acids were extracted from the virus-cell suspen-
sions and nested PCR was used to confer what virus(es)
were there (the methods were mentioned as follows).
Means of diagnosis for 15 respiratory viruses
The viral DNA and RNA were extracted from 200 μL al-
iquots of the NPA samples using the QIAampMinElute
Virus Spin kit (Qiagen, Hilden, Germany). The RNA was
applied as the template for cDNA synthesis using the
SuperScript III First-Strand Synthesis System (Invitro-
gen, California, USA). The DNA and RNA extractions
and cDNA products were used for subsequent testing of
15 respiratory viruses. All the samples were analyzed
using a commercial detection kit (TaKaRa Biotechonol-
ogy, Dalian, China and Applied Biosystems, California,
USA), according to the manufacturer’s instructions. The
15 respiratory viruses detected were as follows [3,16-18]:
RSV subtypes A and B (RSVA, RSVB); IVA, IVB, influenza
virus C (IVC); coronaviruses (CoV-229E, CoV-OC43),
metapneumovirus (MPV), PIV1-4, rhinovirus (RV), HBoV1
and ADV. Real-time PCR was used to detect RV and
HBoV1. Nested PCR assays were used to detect RSVA,
RSVB, IVA, IVB, IVC, CoV-229E, CoV-OC43, MPV, PIV
1–4 and ADV.
Real-time fluorescence quantitative PCR for HBoV1
Amplification of HBoV1 DNA by real-time quantity PCR
was performed with the NS1 primers and probe [19,20].
The plasmid amplified target fragment was cloned into the
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pMD19-T vector (TaKaRa Biotechonology, Dalian, China)
and verified by sequencing. Plasmid DNA concentrations
were detected with an ND-1000 spectrophotometer (Nano-
drop). Real-time fluorescence quantitative PCR was carried
out in a total reaction volume of 20 μL consisting of 10 μL
of TaqMan Universal Master Mix (Applied Biosystems,
California, USA), 0.6 μL (0.6 mM) of each primer, 0.6 μL
(0.3 mM) of the probe, 2 μL of template and 6.2 μL of
double-distilled water. The real-time PCR thermal cycling
reaction and quantitative measurement were performed
in a StepOne Real-Time PCR instrument (Applied
Biosystems, California, USA) using the following condi-
tions: one cycle at 50°C for 2 min, one cycle at 95°C for
10 min, 40 cycles at 95°C for 15 s, and one cycle at 60°C
for 1 min. Each run included plasmid and negative con-
trols. Standard precautions were taken throughout the
PCR process to avoid cross-contamination. Negative
controls and serial dilutions of the positive controls
were included in every PCR assay.
Statistical analyses
The statistical analyses were carried out using the SPSS
17.0 software package. The categorical variables were
compared using the Chi-square test, and the continuous
variables were compared using Student’s t-test or the
nonparametric Mann–Whitney U-test. P-values <0.05 were
considered to be significant.
Results
Demographic and viral findings in children with RTI
During the successive 3.5-year period, 1229 patients with
RTI were included in this study. The median age of
the children was 8 months, varying from 1 month to
203 months, of which 63.1% of the patients were under
12 months (41.9% patients ≤6 months), 15.6% of the pa-
tients were between 1 and 2 years, 15.2% of the patients
were between 2 and 5 years, whereas 6.0% of the pa-
tients were older than 5 years of age. Among the pa-
tients, there were 834 boys and 395 girls, and the sex
ratio was 2.1:1. A potential viral pathogen was identified
in 652 (53.1%) children (Table 1). For 1229 patients,
PCR screening was performed for all 15 viruses and
viral culture was performed for 7 viruses. The PCR re-
sults were positive for ≥1 virus in 652 (53.1%) children.
The viral culture results were positive for ≥1 virus in
288 (23.4%) children. Notably, 266 (21.6%) of the pa-
tients had positive test results for ≥ 2 viruses.
Seasonal distribution of HBoV1
Between December 2009 and August 2013, 127 patients
(10.3%) tested positive for HBoV1 in the NPAs. HBoV1
was the only virus detected in 66 patients (5.4% of all
the patients and 52% of the HBoV1-positive patients).
The pathogen spectrum is shown in Figure 1. Seasonal
variation was observed with a high HBoV1 detection
rate in summer. The seasonal distribution of HBoV1 and
the positive rate in each season are shown in Figure 2.
Quantitative analysis of HBoV1 DNA in the NPAs
The genome viral loads in the NPAs ranged from <500
to 3.8 × 1011 copies/mL of the sample material. The viral
loads were assigned to 2 non-overlapping populations:
one group of 39 samples with a high viral load (≥ 107
copies/mL) and the other group of 88 samples with a
low viral load (<107 copies/mL). The median levels of
the HBoV1 DNA genome in the respiratory samples
were higher in the patients with a single HBoV1 detec-
tion than in the patients with a mixed respiratory viral
infection with HBoV1 (1.95 × 106 copies/mL vs. 3.3 ×
105 copies/mL, P = 0.195) (Figure 3).
HBoV1 co-detection with other respiratory viruses
HBoV1 was a mixed detection in 61 patients (48% of the
HBoV1-positive patients). Of the mixed detection cases,
the most frequently found concurrent co-detection with
HBoV1 were RV (in 37 children), followed by ADV (in
16 children) and RSV (in 13 children). When the clinical
symptoms and severity were compared, no difference
was found between HBoV1 single detection and co-
detection (data not shown). In the high viral load group,
71.8% of the RTI patients were detected as having
HBoV1 single detection whereas 28.2% of the patients
Table 1 Viral etiology of respiratory infection in 1229
children with respiratory tract infections
Viruses No. (%) of children
infected with virus
No. (%) of children infected
with virus as sole agent




197 (16.0) 112 (9.1)
Human bocavirus
1
127 (10.3) 66 (5.4)
Parainfluenza virus
types 1–4
44 (3.6) 12 (1.0)
Adenovirus 88 (7.2) 47 (3.8)
Influenza A, B, and
C viruses
34 (2.7) 24 (2.0)
Coronavirus types
OC43 and 229E
18 (1.5) 9 (0.7)
Human
metapneumovirus






652 (53.1) 386 (31.4)
NOTE: Human coronaviruses, parainfluenza virus type 4, rhinovirus, human
metapneumovirus, and human bocavirus 1 were studied only by PCR;
respiratory syncytial virus, parainfluenza virus type 1–3, adenovirus, and
influenza were studied by viral culture and PCR.
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had HBoV1 co-detection with another virus. In the low
viral load group, 43.2% of the patients had HBoV1 single
detection, and 56.8% of the cases were HBoV1 co-detection
with another virus. When compared with HBoV1-negative
persons, there was a significant difference between
the patients with HBoV1 single detection and the co-
detection group at an HBoV1 high viral load with P =
0.017 (Table 2). These results indicated that HBoV1 at
a high viral load was not frequently co-detection with
other respiratory viruses.
Association of HBoV1 and SRTI
An HBoV1 low load was found significantly more fre-
quently than was HBoV1 with a high viral load in chil-
dren. Of the HBoV1 single detection occurrences, a high
viral load was more prevalent among children with dys-
pnea and wheezing than was a low viral load (42.9% vs.
23.7%, P = 0.036; 60.7% vs. 31.6%, P = 0.018). In clinical
severity, a significant difference was recorded (25.0% vs.
5.3%, P = 0.003) between the high viral load and low viral
load group (Table 3). We analyzed 18 HBoV1-positive
patients who suffered from SRTI to study the association
between HBoV1 and SRTI. Fourteen children had a
diagnosis of severe pneumonia, 3 children had severe
bronchiolitis, and 1 child had plastic bronchitis. Ten of
18 (55.6%) patients had a high HBoV1 load and only 3
of 10 children had other co-detected viruses, whereas 7
in 10 children with HBoV1 single detected were diag-
nosed with SRTI. The other 8 children who were diag-
nosed with SRTI had a low HBoV1 load. Among these 8
children, only 2 children were with HBoV1 single de-
tected, whereas the other 6 children were co-detected
with ADV, RSV or RV. HBoV1 single infection was more
prevalent in the children with a high viral load than in
those with a low viral load (70% vs. 25%) in the severe
cases.
The clinical data of children of HBoV1 single detection at
a high viral load
There were 7 children with HBoV1 single detection and
a high viral load who had severe pneumonia or bron-
chiolitis. The demographic and clinical characteristics
are shown in Table 4. The median age of the patients
was 9 months (range, 3–22 months). Among the pa-
tients, there were 3 boys and 4 girls. The median hos-
pital stay was 8 days (range, 5–33 days), and the median
duration of symptoms before admission was 4 days
(range, 1–15 days). Underlying conditions included con-
genital cardiac condition, pulmonary conditions, primary
Figure 1 Pathogen spectrum of 1229 patients hospitalized with
respiratory tract infections.
Figure 2 Seasonal distribution of HBoV1 and the positive rate
in each season.
Figure 3 Distribution of the HBoV1 loads among 127
nasopharyngeal aspirate samples that tested positive for
HBoV1. Each sample is represented by a single dot. The dotted line
indicates the cutoff between the high and low HBoV1 load groups
discussed in the text. The comparison in the mean viral load
between HBoV1 high and low viral load groups were conducted by
nonparametric Mann–Whitney U-test.
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immunodeficiency or prematurity (<37 weeks), anemia
and malnutrition. All the children had cough and dys-
pnea, 5 had fever and wheezing, 3 had diarrhea and 2
children received treatment in ICU. The patient in case
1 had right lower pulmonary atelectasis and required
ICU treatment for 25 days, with ventilator assisted
breathing for 7 days. The patient in case 7 remained in
ICU for 8 days, with ventilator assisted breathing for
5 days. Chest radiography showed 6 cases with pulmon-
ary inflammation (one patient did not have a chest radi-
ography test). Only one case (case 1) had complications,
and the prognosis was positive; 4 children were discharged
after 5–12 days of hospitalization whereas the other 3 chil-
dren were improving after 8–33 days of hospitalization and
subsequently recovered.
Discussion
This study confirms that HBoV1 is frequently found in
children with RTI. We conducted this study for nearly 4
consecutive years, and samples were analyzed for 15
respiratory viruses by PCR and viral culture. The HBoV1
viral load was quantified by real-time fluorescence quan-
titative PCR. The results suggest that HBoV1 at a high
viral load (≥107 copies/mL) is not co-detected frequently
with other respiratory viruses; there would be an associ-
ation between HBoV1 single detection at a high viral
load and SRTI.
This study investigated the role of HBoV1 in RTI and
found that 10.3% of the children with RTI were HBoV1
positive in the NPAs. Multiple studies have confirmed
the presence of HBoV1 in respiratory tract samples of
children world wide [7,21,22]. Some reports indicate that
HBoV1 infection is associated with acute respiratory
tract symptoms and that a high HBoV1 load (≥107 cop-
ies/mL) is associated with SRTI [14,23]. In this study,
HBoV1 low load was found significantly more frequently
in children than was HBoV1 with a high viral load. The
cases of SRTI in the patients with HBoV1 detection
alone appeared to be particularly common among chil-
dren with a high HBoV1 load. The stratification of the
patients on the basis of the HBoV1 viral load ≥107 cop-
ies/mL versus <107 copies/mL in NPAs revealed that the
presence of HBoV1 single detection at high (≥107 cop-
ies/mL)—but not at low (<107 copies/mL)—viral loads is
associated with SRTI. Similarly, a case report described
HBoV detection leading to SRTI [24]. Zhao found an as-
sociation between disease severity and the HBoV1 viral
load in co-detection children [14]. Our study reported
an association between the HBoV1 high viral load and
SRTI in single detection children. We confirmed HBoV1
single detection at a high viral load in 7 children. Two of
them received treatment in ICU, including ventilator
Table 2 The distribution of patients by the presence of
HBoV1, the viral load in the NPAs, and the presence or
absence of other viruses
Patient group
No. of patients
PaNo. (%) of children
with other virus
detected
No. (%) of children




61 (48.0) 66 (52.0) 1.00
≥107copies/mL 11 (28.2) 28 (71.8) 0.017
<107copies/mL 50 (56.8) 38 (43.2) 0.097
HBoV1-negative
subjects
525 (47.6) 577 (52.4)
All subjects 652 (53.1) 577 (46.9)
NOTE: a.Compared with HBoV1-negative persons; determined by the
Chi-square test.
Table 3 Comparison of demographic and clinical
characteristics of patients hospitalized for HBoV1 single









Gender (Male) 22 (57.9) 15 (53.6) 0.727
Age (months) 11 (1–151) 9.5 (1–33) 0.846
Duration of symptoms
before admission (days)
7 (1–90) 9.5 (1–30) 0.974
Duration of hospitalization
(days)
7 (3–28) 7 (3–33) 0.642
Pulse rate (/min) 125 (85–
168)
124 (50–180) 0.507
Respiratory rate (/min) 41 (25–58) 45 (28–67) 0.144
White blood cell
(×109 cells/mL)
9.6 (4–23.2) 12.6 (6.4-
23.3)
0.056
Fever 20 (52.6) 16 (57.1) 0.716
Cough 34 (89.5) 27 (96.4) 0.385
Dyspnea 9 (23.7) 12 (42.9) 0.036
Rhinorrhea 8 (21.1) 3 (10.7) 0.331
Diarrhea 12 (31.6) 9 (32.1) 0.961
Wheezing 12 (31.6) 17 (60.7) 0.018
Abnormality on chest
radiographa
30 (100) 19 (95.0) 0.400
Severity 2 (5.3) 7 (25.0) 0.003
Upper respiratory tract infection 1 (2.6) 0 (0) 1.000
Lower respiratory tract infection
Pneumonia 28 (73.7) 18 (64.3) 0.437
Bronchiolitis 3 (7.9) 3 (10.7) 0.693
Bronchitis 1 (2.6) 3 (10.7) 0.304
Asthma 5 (13.2) 4 (14.3) 1.000
NOTE: Data presented as median (range) or frequency (percentage) of
patients. a.There were 30 patients who had a chest radiograph test in the
HBoV1 load <107 group, and there were 20 patients in the HBoV1 load
≥107group. Categorical variables were compared using the Chi-square test,
and the continuous variables were compared using Student’s t-test or the
nonparametric Mann–Whitney U-test.
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Table 4 Seven cases with human bocavirus1 single infection at high viral load associated with severe respiratory tract
infections
Case 1 Case 2 Case 3 Case 4 Case 5 Case 6 Case 7
HBoV1 viral load
(copies/mL)
3.8 × 1011 7.9 × 108 7.4 × 108 2.5 × 107 6.5 × 109 5.1 × 109 8.4 × 108
Gender Female Male Female Male Female Female Male
Age (months) 10 3 9 22 9 9 12
Underlying disease With mild anemia No Born at 34 weeks No Born at
28 weeks







7 9 15 1 3 4 3
Duration of
hospitalization (days)
33 12 6 5 7 8 20
Fever Yes Yes No No Yes Yes Yes
Cough Yes Yes Yes Yes Yes Yes Yes
Rhinorrhea No No Yes No Yes No Yes
Wheezing Yes No Yes Yes No Yes Yes
Dyspnea Yes Yes Yes Yes Yes Yes Yes
Diarrhea No Yes No No Yes Yes No
Weight on admission
(kg)
6.0 7.3 6.0 11.0 9.0 7.0 8.0
Body temperature (°C) 38.8 37.7 37.0 37.0 38.4 37.4 39.1
Respiratory rate (/min) 30 67 58 32 50 49 62
Pulse rate (/min) 124 180 145 50 160 145 148
White blood cell (×109
cells/mL)
10.3 15.3 20.6 14.3 12.7 11.8 8.9
Neutrophil granulocyte
%
61 26 34 85 68 32 68
Hemoglobin (g/l) 97 107 120 125 120 94 106
Lymphocyte % 35 70 61 12 25 67 26
Platelets (109/L) 354 420 457 352 273 499 265
Chest radiograph Yesa Yesb Yesc - Yesb Yesb Yesd
Abnormality in blood
culture
No No No No No No No
Bacterium in sputum
culture









Yes No No No No No Yes
Complication The right lower
pulmonary
atelectasis













Prognosis Recover Cure Cure Cure Cure Recover Recover
Note: aDouble lung inflammation, right lower pulmonary atelectasis; bDouble lung texture fuzzy, with visible flocculent shadow and lung inflation is a bit
excessive; cDouble lung inflammation, light transmittance in left lung is higher than the right lung; dDouble lung lesions, the consolidation of the right lung is
obvious. eThe patient in case 1 received ICU treatment for 25 days and ventilator assisted breathing for 7 days. The patient in case 7 received ICU treatment for
8 days and ventilator assisted breathing for 5 days.
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assisted breathing. These cases demonstrate that a lower
respiratory tract infection caused by HBoV1 single de-
tection at a high viral load could lead to a severe and
life-threatening disease.
In most of the previous studies, the co-detection rate
ranged from 18-72% [25]. In this study, of the HBoV1
positive samples, 48% were co-detected with other re-
spiratory viruses (HBoV1-RV in 37 children, followed by
HBoV1-ADV in 16 children and HBoV1-RSV in 13
children). This result is consistent with more recent
studies. Martin reported that 35.3% of HBoV cases were
co-infected, and 83.3% of them were HBoV-RSV co-
infection [7]. Another study reported that RSV and RV
were most frequently detected in conjunction with HBoV1
[26], and ADV and enterovirus were more common in chil-
dren with HBoV [5]. We compared HBoV1 single detection
and co-detection, and the median level of HBoV1 load was
greater in the subjects with HBoV1 infection alone than in
the subjects with mixed respiratory viral infections. There
were no differences in the clinical symptoms and severity.
Co-detection with HBoV1 did not increase the severity of
RTI. High viral loads of HBoV1 were noted predominantly
in the absence of other viral agents, whereas co-detections
were primarily found in low viral load cases. In severe
cases, HBoV1 single detection was more prevalent
among the children with a high viral load than those
with a low viral load.
Recently, some studies reported that HBoV was likely
to persist in respiratory samples of asymptomatic pa-
tients [27,28]. Cashman also showed that HBoV1 was
found in stool samples of asymptomatic patients [29].
Allander suggested a model for HBoV infection in which
high viral loads are potentially associated with respira-
tory symptoms, and low viral loads indicate asymptom-
atic shedding [3]. In our study, a portion of patients with
HBoV1 single detections at low viral load suffered from
acute respiratory tract disease. What’s more, Schildgen
suggested that HBoV may indirectly contribute to the
development of some colorectal and lung cancers or
may play an active role in cancer by interacting with the
host genome [30]. Thus, it is hard to make a conclusion
that a portion of HBoV single detections with low copy
number is always accompanied by a lack of symptoms. The
role of HBoV is sometimes as a passenger and sometimes
as a pathogen in acute respiratory tract disease.
One of the limitations in this report is that this study
included only hospitalized patients with RTI and was
lack of a control group (individuals without respiratory
symptoms). Secondly, we did not detect the HBoV1
DNA load and culture HBoV1 in the serum samples and
serological analysis for IgM and IgG. The most reliable
methods for diagnosis of acute symptomatic HBoV in-
fections are PCR of serum samples and serological ana-
lysis for IgM and IgG [31]. Christensen suggested that,
for clinical purposes, HBoV mRNA is more accurate
than HBoV DNA in diagnosing active HBoV infection;
however, a high HBoV DNA load (>107 copies/mL)
might be useful for the diagnosis [8].
Conclusion
In conclusion, HBoV1 is a prevalent virus commonly
detected in hospitalized children with RTI especially in
children below 2 years of age. During the study period,
the high detection of HBoV1 was predominantly in
May-August and November-January. Of the HBoV1 sin-
gle detection cases, the high viral load group was more
prevalent than the low viral load group among the chil-
dren with dyspnea and wheezing. The disease severity in
the high viral load group was greater than the severity of
the low viral load group. The 7 cases reported here sug-
gest that a lower respiratory tract infection caused by
HBoV1 single detection at a high viral load (≥107 copies/
mL) could lead to severe and life-threatening disease.
HBoV1 could in some cases be a passenger in RTI, pri-
marily in the low viral load group. HBoV1 co-detection
with other respiratory viruses did not increase the sever-
ity of RTI. However, the role of HBoV1 detection in
SRTI merits further study.
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